BANADO Trademark

Trademark Overview


On Tuesday, January 29, 2013, a trademark application was filed for BANADO with the United States Patent and Trademark Office. The USPTO has given the BANADO trademark a serial number of 85835264. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, September 15, 2014. This trademark is owned by Glaxo Group Limited. The BANADO trademark is filed in the Pharmaceutical Products category with the following description:

(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the tre...
banado

General Information


Serial Number85835264
Word MarkBANADO
Filing DateTuesday, January 29, 2013
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, September 15, 2014
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, June 18, 2013

Trademark Statements


Goods and Services(Based on Intent to Use) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(d) Priority Application) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines(Based on 44(e)) Pharmaceutical preparations and substances for the treatment of damaged skin and tissue; Pharmaceutical preparations and substances for the treatment of infectious diseases, blood disorders, pain, inflammation, sepsis, alopecia, obesity and cognitive disorders; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Vaccines
Translation of Words in MarkThe wording "BANADO" has no meaning in a foreign language.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, February 4, 2013
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGlaxo Group Limited
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Party NameGlaxo Group Limited
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressBrentford, Middlesex TW89GS
GB

Trademark Events


Event DateEvent Description
Monday, September 15, 2014ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED
Monday, September 15, 2014ABANDONMENT - NO USE STATEMENT FILED
Thursday, February 13, 2014NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 11, 2014EXTENSION 1 GRANTED
Tuesday, February 11, 2014EXTENSION 1 FILED
Tuesday, February 11, 2014TEAS EXTENSION RECEIVED
Tuesday, August 13, 2013NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, June 18, 2013OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 18, 2013PUBLISHED FOR OPPOSITION
Wednesday, May 29, 2013NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, May 13, 2013ELECTRONIC RECORD REVIEW COMPLETE
Friday, May 10, 2013ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Monday, May 6, 2013APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, May 2, 2013ASSIGNED TO EXAMINER
Wednesday, March 20, 2013APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Wednesday, March 20, 2013TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, February 4, 2013NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, February 1, 2013NEW APPLICATION ENTERED IN TRAM